Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

NCT02952508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Central Nervous System Lymphoma, +36 more
Locations
  • Cellectar Biosciences site Los Angeles, California, United States
  • Cellectar Biosciences site Redlands, California, United States
  • Cellectar Biosciences site Washington D.C., District of Columbia, United States
  • Cellectar Biosciences site Jacksonville, Florida, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)

NCT04416984

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

NCT06846606

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT05527184

Conditions
Adnexal Diseases, Cervical Cancer, Disease Attributes, +23 more
Locations
  • University of Alabama at Birmingham /ID# 269045 Birmingham, Alabama, United States
  • City of Hope National Medical Center /ID# 269036 Duarte, California, United States
  • Moores Cancer Center /ID# 269040 La Jolla, California, United States
  • University of California Los Angeles Medical Center /ID# 269037 Los Angeles, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • University Hospital Gent Ghent, Belgium
  • CH Tourelle Peltzer Verviers, Belgium
  • CHU Mont-Godinne Yvoir, Belgium
View all 22 locations
View Trial Details
Active, Not Recruiting

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

NCT03930953

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Local Institution - 109 Scottsdale, Arizona, United States
  • Local Institution - 111 Jacksonville, Florida, United States
  • Local Institution - 102 Tampa, Florida, United States
  • Local Institution - 108 Overland Park, Kansas, United States
View all 66 locations
View Trial Details

Related conditions